−Removed: We establish the geographic locations of our research and development operations based on proximity to the relevant market expertise and access to available talent pools.
+Added: We establish the geographic locations of our research and development operations and production facilities based on proximity to the relevant market expertise and access to available talent pools.
The following table shows information about our primary lab operations used in our healthcare operations as of December 31, 2025:
Location Square Footage
−Removed: Germantown, Maryland (Biopharmaceuticals segment) 61,048
−Removed: Our primary domestic production and lab facilities, for our Exemplar segment, is located in Sioux County and Johnson County, Iowa, and include approximately 57,960 square feet of production, lab, and office facilities.
−Removed: Our primary administrative offices, including our manufacturing capabilities for our lead product candidate, are in Germantown, Maryland.
+Added: Germantown, Maryland 61,048
+Added: Our primary domestic production and lab facilities for Exemplar are located in Sioux County and Johnson County, Iowa, and include approximately 57,711 square feet of production, lab, and office facilities.
+Added: Our primary administrative offices, including our manufacturing facility for Papzimeos, are located in Germantown, Maryland.
See also "Management's Discussion and Analysis of Financial Condition and Results of Operations — Contractual Obligations and Commitments" appearing elsewhere in this Annual Report.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.